These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27599779)

  • 21. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
    Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma.
    Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X
    Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma.
    Jiao W; Xu J; Zheng J; Shen Y; Lin L; Li J
    BMC Cancer; 2008 Nov; 8():334. PubMed ID: 19014602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
    He Z; Li W; Zheng T; Liu D; Zhao S
    J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zheng S; Zhang X; Wang X; Li J
    Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.
    Jin Y; Meng Q; Zhang B; Xie C; Chen X; Tian B; Wang J; Shih TC; Zhang Y; Cao J; Yang Y; Chen S; Guan X; Chen X; Hong A
    Int J Biol Sci; 2021; 17(14):3689-3701. PubMed ID: 34671193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel serum microRNA signature to screen esophageal squamous cell carcinoma.
    Huang Z; Zhang L; Zhu D; Shan X; Zhou X; Qi LW; Wu L; Zhu J; Cheng W; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Cancer Med; 2017 Jan; 6(1):109-119. PubMed ID: 28035762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.
    Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O
    Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma.
    Zhang C; Guo Z; Jing Z
    Int J Nanomedicine; 2024; 19():1351-1362. PubMed ID: 38352821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
    He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
    World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
    Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
    Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR-206 to upregulate NETO2 and FOXP1 expression.
    Zhang C; Luo Y; Cao J; Wang X; Miao Z; Shao G
    Cancer Med; 2020 Nov; 9(22):8600-8611. PubMed ID: 33006432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
    Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
    Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.
    Hu D; Lin X; Chen Y; Chang Q; Chen G; Li C; Zhang H; Cui Z; Liang B; Jiang W; Ji K; Huang J; Peng F; Zheng X; Niu W
    Oncotarget; 2017 Apr; 8(14):23841-23850. PubMed ID: 27852044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.